Similar articles

• Unique PABPN1 gene mutation in a large Bulgarian family with OPMD.

  Mihaylova V, Müller T, Petrova I, Tournev I, Cherninkova S, Walter MC, Deschauer M. Mihaylova V, et al. J Neurol. 2008 Apr;255(4):609-11. doi: 10.1007/s00415-008-0769-y. Epub 2008 Feb 19. J Neurol. 2008. PMID: 18274805 No abstract available.
• Oculopharyngeal muscular dystrophy with PABPN1 mutation in a Chinese Malaysian woman.

  Goh KJ, Wong KT, Nishino I, Minami N, Nonaka I. Goh KJ, et al. Neuromuscul Disord. 2005 Mar;15(3):262-4. doi: 10.1016/j.nmd.2004.10.016. Epub 2005 Jan 28. Neuromuscul Disord. 2005. PMID: 15725589
• [Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene].

  Pou Serradell A, Lloreta Trull J, Corominas Torres JM, Hammouda EH, Urtizberea JA, Richard P, Brais B. Pou Serradell A, et al. Neurologia. 2004 Jun;19(5):239-47. Neurologia. 2004. PMID: 15150706 Spanish.
• Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.

  Brais B. Brais B. Cytogenet Genome Res. 2003;100(1-4):252-60. doi: 10.1159/000072861. Cytogenet Genome Res. 2003. PMID: 14526187 Review.
• Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder.

  Davies JE, Berger Z, Rubinsztein DC. Davies JE, et al. Int J Biochem Cell Biol. 2006;38(9):1457-62. doi: 10.1016/j.biocel.2006.01.016. Epub 2006 Feb 28. Int J Biochem Cell Biol. 2006. PMID: 16530457 Review.